2008 - Review: Low-molecular-weight heparin is better than unfractionated heparin to prevent VTE after ischemic stroke

Uchino, Ken
July 2008
ACP Journal Club;7/15/2008, Vol. 149 Issue 1, p7
Academic Journal
The article presents a study that was conducted by A.F. Shorr and colleagues on prevention of venous thromboembolism (VTE) more than unfractioned heparin (UFH) in patients with ischemic stroke due to low-molecular-weight heparin (LMWH). The study compared LWMH with UFH for VTE prophylaxis in patients with ischemic stroke. Meta-analysis showed that LMWH reduced overall VTE, proximal VTE, and PE more than UFH.


Related Articles

  • 2008 - Review: Late percutaneous coronary intervention after AMI improves survival more than optimal medical therapy. Brott, Brigitta C.; Hillegass, William B. // ACP Journal Club;7/15/2008, Vol. 149 Issue 1, p5 

    The article presents a study that was conducted by A. Abbate and colleagues on late percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI) improves survival more than optimal medical therapy. The study compared late PCI of the infarct-related artery (IRA) plus medical...

  • Role of Pre-procedural C-reactive Protein Level in the Prediction of Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention: a Meta-analysisof Longitudinal Studies. Bibek, Singh-baniya; Xie, Yong; Gao, Jia-jia; Wang, Zhi; Wang, Jing-feng; Geng, Deng-feng // Inflammation;Feb2015, Vol. 38 Issue 1, p159 

    Numerous studies have reported the relation between pre-procedural C-reactive protein (CRP) levels and the risk of major adverse cardiac events (MACEs) in patients undergoing percutaneous coronary intervention (PCI). However, the results across the studies were inconsistent. The aim of this...

  • Traditional versus modern anticoagulant strategies: Summary of the literature. Nutescu, Edith; Racine, Eric // American Journal of Health-System Pharmacy;10/15/2002, Vol. 59 Issue 20, pS7 

    Traditional and modern anticoagulant therapies for the management, prophylaxis, and treatment of venous thromboembolism (VTE) and acute coronary syndrome (ACS) and key findings of primary studies are summarized, Significant advances have been made during the past decade in the prevention and...

  • ANTICOAGULANT THERAPY TODAY. Vigran, I. Myron // Angiology;Jan1964, Vol. 15 Issue 1, p1 

    A review has been presented of some of the more classical and recent findings in regard to results of anticoagulant therapy in acute myocardial infarction, the long-term prophylactic treatment of coronary artery disease, the use of anticoagulant therapy in cerebral vascular disease, as well as...

  • Treatment Options in Acute Coronary Syndromes: Focus on Fondaparinux Sodium. Reindl, Iris; Schlitt, Axel // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p869 

    Anticoagulants are the mainstay for treating thromboembolism and acute coronary syndromes (ACS). In comparison to heparin newer agents such as bivalirudin and fondaparinux have improved the outcome of ACS in patients managed by using an invasive or conservative strategy, respectively. Using...

  • Should you add aspirin to your heart patient's warfarin regimen?  // Journal of Family Practice;Jun2007, Vol. 56 Issue 6, p430 

    The article discusses the studies on the use of aspirin with warfarin regimens for cardiac patients. The study showed that aspirin does not reduce the risk of death or thromboembolism in patients with coronary artery disease. However, it showed that it brings benefits to patients with mechanical...

  • Early Invasive vs Conservative Treatment Strategies in Women and Men With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. O'Donoghue, Michelle; Boden, William E.; Braunwald, Eugene; Cannon, Christopher P.; Clayton, Tim C.; de Winter, Robbert J.; Fox, Keith A. A.; Lagerqvist, Bo; McCullough, Peter A.; Murphy, Sabina A.; Spacek, Rudolf; Swahn, Eva; Wallentin, Lars; Windhausen, Fons; Sabatine, Marc S. // JAMA: Journal of the American Medical Association;7/2/2008, Vol. 300 Issue 1, p71 

    The article presents a meta-analysis of randomized trials comparing the effects and outcomes of an invasive versus a conservative strategy in the treatment of male and female patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS). The criteria for data source searching, study...

  • ISCHAEMIC HEART DISEASE. Gorog, Dianna; Kapur, Akhil; Khan, Masood; Lindsay, Alistair; Sharp, Andrew // Heart;Apr2004, Vol. 90 Issue 4, p471 

    This article reports on some developments in research related to ischaemic heart disease. In a meta-analysis of 12 trials, low molecular weight heparin was associated with a non-significant decrease in recurrent symptomatic venous thromboembolism at the end of treatment. Warfarin for six months...

  • Outcomes in ACS: GP IIb/IIIa inhibitor plus LMWH superior to GPs plus unfractionated heparin.  // Formulary;May2002, Vol. 37 Issue 5, p252 

    Focuses on the improvement of heparin enoxaparin compared with the recommended therapy in patients with non-ST-segment elevation acute coronary syndromes (ACS). Reduction of cardiac events in patients with ACS; Study designed to solve the safety and efficacy of combination therapy; Rate of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics